<html>
<head>
<title>Utah Legislature HB0094</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>INVESTIGATIONAL DRUG AND DEVICE ACCESS FOR</b></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><center>TERMINALLY ILL PATIENTS</b></font><font face="Arial" size="2"></center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2015 GENERAL SESSION</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Gage Froerer</b></font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor: </font><font face="Arial" size="2"></font><font face="Arial" size="3">  Evan J. Vickers</font><font face="Arial" size="2"></center><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill amends provisions related to investigational drugs and devices.<br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provides that a terminally ill patient may obtain an investigational drug or device<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from the drug's or device's manufacturer under certain circumstances; and<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;exempts certain conduct from the definition of unlawful and unprofessional conduct<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for a physician who administers an investigational drug or uses an investigational<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;device to treat a terminally ill patient.<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDS:<br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-67-501">58-67-501</a></b>, as last amended by Laws of Utah 2001, Chapter 116<br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-67-502">58-67-502</a></b>, as last amended by Laws of Utah 2014, Chapter 72<br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-68-501">58-68-501</a></b>, as last amended by Laws of Utah 2001, Chapter 116<br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-68-502">58-68-502</a></b>, as last amended by Laws of Utah 2014, Chapter 72<br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ENACTS:<br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-85-101">58-85-101</a></b>, Utah Code Annotated 1953<br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-85-102">58-85-102</a></b>, Utah Code Annotated 1953<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-85-103">58-85-103</a></b>, Utah Code Annotated 1953<br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-85-104">58-85-104</a></b>, Utah Code Annotated 1953<br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>58-67-501</b><a name="58-67-501"></a> is amended to read:<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-67-501.</b>   <b>Unlawful conduct.</b><br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  "Unlawful conduct" includes, in addition to the definition in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2015GS">58-1-501</a>:<br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  buying, selling, or fraudulently obtaining, any medical diploma, license, certificate,<br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or registration;<br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  aiding or abetting the buying, selling, or fraudulently obtaining of any medical<br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;diploma, license, certificate, or registration;<br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  substantially interfering with a licensee's lawful and competent practice of medicine<br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in accordance with this chapter by:<br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  any person or entity that manages, owns, operates, or conducts a business having a<br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;direct or indirect financial interest in the licensee's professional practice; or<br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  anyone other than another physician licensed under this title, who is engaged in<br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;direct clinical care or consultation with the licensee in accordance with the standards and ethics<br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of the profession of medicine; or<br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  entering into a contract that limits a licensee's ability to advise the licensee's<br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patients fully about treatment options or other issues that affect the health care of the licensee's<br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patients.<br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  "Unlawful conduct" does not include:<br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  establishing, administering, or enforcing the provisions of a policy of accident and<br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;health insurance by an insurer doing business in this state in accordance with Title 31A,<br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance Code;<br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  adopting, implementing, or enforcing utilization management standards related to<br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;payment for a licensee's services, provided that:<br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  utilization management standards adopted, implemented, and enforced by the payer<br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;have been approved by a physician or by a committee that contains one or more physicians; and<br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the utilization management standards does not preclude a licensee from exercising<br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;independent professional judgment on behalf of the licensee's patients in a manner that is<br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;independent of payment considerations;<br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  developing and implementing clinical practice standards that are intended to reduce<br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;morbidity and mortality or developing and implementing other medical or surgical practice<br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;standards related to the standardization of effective health care practices, provided that:<br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the practice standards and recommendations have been approved by a physician or<br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by a committee that contains one or more physicians; and<br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the practice standards do not preclude a licensee from exercising independent<br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;professional judgment on behalf of the licensee's patients in a manner that is independent of<br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;payment considerations;<br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  requesting or recommending that a patient obtain a second opinion from a licensee;<br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)  conducting peer review, quality evaluation, quality improvement, risk management,<br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or similar activities designed to identify and address practice deficiencies with health care<br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;providers, health care facilities, or the delivery of health care;<br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)  providing employment supervision or adopting employment requirements that do<br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not interfere with the licensee's ability to exercise independent professional judgment on behalf<br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of the licensee's patients, provided that employment requirements that may not be considered to<br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;interfere with an employed licensee's exercise of independent professional judgment include:<br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  an employment requirement that restricts the licensee's access to patients with<br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;whom the licensee's employer does not have a contractual relationship, either directly or<br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;through contracts with one or more third-party payers; or<br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  providing compensation incentives that are not related to the treatment of any<br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;particular patient;<br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)  providing benefit coverage information, giving advice, or expressing opinions to a<br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patient or to a family member of a patient to assist the patient or family member in making a<br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;decision about health care that has been recommended by a licensee; [<strike>or</strike>]<br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(h)  in compliance with Section <a href="#58-85-103">58-85-103</a>:</u><br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  obtaining an investigational drug or investigational device;</u><br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  administering the investigational drug to an eligible patient; or</u><br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  treating an eligible patient with the investigational drug or investigational device;</u><br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>or</u><br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(h)</strike>] <u>(i)</u>  any otherwise lawful conduct that does not substantially interfere with the<br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee's ability to exercise independent professional judgment on behalf of the licensee's<br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patients and that does not constitute the practice of medicine as defined in this chapter.<br/>95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.  Section <b>58-67-502</b><a name="58-67-502"></a> is amended to read:<br/>96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-67-502.</b>   <b>Unprofessional conduct.</b><br/>97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)</u>  "Unprofessional conduct" includes, in addition to the definition in Section<br/>98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2015GS">58-1-501</a>:<br/>99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)</strike>] <u>(a)</u>  using or employing the services of any individual to assist a licensee in any<br/>100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;manner not in accordance with the generally recognized practices, standards, or ethics of the<br/>101&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;profession, state law, or division rule;<br/>102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(2)</strike>] <u>(b)</u>  making a material misrepresentation regarding the qualifications for licensure<br/>103&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;under Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-67-302.7&session=2015GS">58-67-302.7</a>; or<br/>104&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(3)</strike>] <u>(c)</u>  violating the dispensing requirements of Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-309&session=2015GS">58-17b-309</a> or Chapter 17b,<br/>105&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy,<br/>106&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if applicable.<br/>107&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  "Unprofessional conduct" does not include, in compliance with Section <a href="#58-85-103">58-85-103</a>:</u><br/>108&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  obtaining an investigational drug or investigational device;</u><br/>109&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  administering the investigational drug to an eligible patient; or</u><br/>110&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  treating an eligible patient with the investigational drug or investigational device.</u><br/>111&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.  Section <b>58-68-501</b><a name="58-68-501"></a> is amended to read:<br/>112&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-68-501.</b>   <b>Unlawful conduct.</b><br/>113&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  "Unlawful conduct" includes, in addition to the definition in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2015GS">58-1-501</a>:<br/>114&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  buying, selling, or fraudulently obtaining any osteopathic medical diploma, license,<br/>115&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;certificate, or registration; and<br/>116&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  aiding or abetting the buying, selling, or fraudulently obtaining of any osteopathic<br/>117&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;medical diploma, license, certificate, or registration;<br/>118&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  substantially interfering with a licensee's lawful and competent practice of medicine<br/>119&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in accordance with this chapter by:<br/>120&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  any person or entity that manages, owns, operates, or conducts a business having a<br/><hr>121&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;direct or indirect financial interest in the licensee's professional practice; or<br/>122&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  anyone other than another physician licensed under this title, who is engaged in<br/>123&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;direct clinical care or consultation with the licensee in accordance with the standards and ethics<br/>124&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of the profession of medicine; or<br/>125&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  entering into a contract that limits a licensee's ability to advise the licensee's<br/>126&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patients fully about treatment options or other issues that affect the health care of the licensee's<br/>127&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patients.<br/>128&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  "Unlawful conduct" does not include:<br/>129&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  establishing, administering, or enforcing the provisions of a policy of accident and<br/>130&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;health insurance by an insurer doing business in this state in accordance with Title 31A,<br/>131&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance Code;<br/>132&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  adopting, implementing, or enforcing utilization management standards related to<br/>133&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;payment for a licensee's services, provided that:<br/>134&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  utilization management standards adopted, implemented, and enforced by the payer<br/>135&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;have been approved by a physician or by a committee that contains one or more physicians; and<br/>136&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the utilization management standards does not preclude a licensee from exercising<br/>137&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;independent professional judgment on behalf of the licensee's patients in a manner that is<br/>138&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;independent of payment considerations;<br/>139&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  developing and implementing clinical practice standards that are intended to reduce<br/>140&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;morbidity and mortality or developing and implementing other medical or surgical practice<br/>141&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;standards related to the standardization of effective health care practices, provided that:<br/>142&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the practice standards and recommendations have been approved by a physician or<br/>143&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by a committee that contains one or more physicians; and<br/>144&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the practice standards do not preclude a licensee from exercising independent<br/>145&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;professional judgment on behalf of the licensee's patients in a manner that is independent of<br/>146&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;payment considerations;<br/>147&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  requesting or recommending that a patient obtain a second opinion from a licensee;<br/>148&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)  conducting peer review, quality evaluation, quality improvement, risk management,<br/>149&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or similar activities designed to identify and address practice deficiencies with health care<br/>150&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;providers, health care facilities, or the delivery of health care;<br/>151&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)  providing employment supervision or adopting employment requirements that do<br/><hr>152&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not interfere with the licensee's ability to exercise independent professional judgment on behalf<br/>153&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of the licensee's patients, provided that employment requirements that may not be considered to<br/>154&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;interfere with an employed licensee's exercise of independent professional judgment include:<br/>155&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  an employment requirement that restricts the licensee's access to patients with<br/>156&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;whom the licensee's employer does not have a contractual relationship, either directly or<br/>157&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;through contracts with one or more third-party payers; or<br/>158&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  providing compensation incentives that are not related to the treatment of any<br/>159&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;particular patient;<br/>160&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)  providing benefit coverage information, giving advice, or expressing opinions to a<br/>161&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patient or to a family member of a patient to assist the patient or family member in making a<br/>162&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;decision about health care that has been recommended by a licensee; [<strike>or</strike>]<br/>163&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(h)  in compliance with Section <a href="#58-85-103">58-85-103</a>:</u><br/>164&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  obtaining an investigational drug or investigational device;</u><br/>165&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  administering the investigational drug to an eligible patient; or</u><br/>166&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  treating an eligible patient with the investigational drug or investigational device;</u><br/>167&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>or</u><br/>168&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(h)</strike>] <u>(i)</u>  any otherwise lawful conduct that does not substantially interfere with the<br/>169&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee's ability to exercise independent professional judgment on behalf of the licensee's<br/>170&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patients and that does not constitute the practice of medicine as defined in this chapter.<br/>171&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4.  Section <b>58-68-502</b><a name="58-68-502"></a> is amended to read:<br/>172&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-68-502.</b>   <b>Unprofessional conduct.</b><br/>173&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)</u>  "Unprofessional conduct" includes, in addition to the definition in Section<br/>174&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2015GS">58-1-501</a>:<br/>175&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)</strike>] <u>(a)</u>  using or employing the services of any individual to assist a licensee in any<br/>176&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;manner not in accordance with the generally recognized practices, standards, or ethics of the<br/>177&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;profession, state law, or division rule; or<br/>178&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(2)</strike>] <u>(b)</u>  violating the dispensing requirements of Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-309&session=2015GS">58-17b-309</a> or Chapter 17b,<br/>179&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy,<br/>180&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if applicable.<br/>181&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  "Unprofessional conduct" does not include, in compliance with Section <a href="#58-85-103">58-85-103</a>:</u><br/>182&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  obtaining an investigational drug or investigational device;</u><br/><hr>183&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  administering the investigational drug to an eligible patient; or</u><br/>184&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  treating an eligible patient with the investigational drug or investigational device.</u><br/>185&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.  Section <b>58-85-101</b><a name="58-85-101"></a> is enacted to read:<br/>186&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>CHAPTER 85.  UTAH RIGHT TO TRY ACT</b></center><br/>187&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-85-101.</u></b>  <b>Title.</b><br/>188&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>This chapter is known as the "Utah Right to Try Act."</u><br/>189&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 6.  Section <b>58-85-102</b><a name="58-85-102"></a> is enacted to read:<br/>190&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-85-102.</u></b>  <b>Definitions.</b><br/>191&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>As used in this chapter:</u><br/>192&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  "Eligible patient" means an individual who has been diagnosed with a terminal</u><br/>193&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>illness by a physician.</u><br/>194&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  "Physician" means an individual who is licensed under:</u><br/>195&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  Title 58, Chapter 67, Utah Medical Practice Act; or</u><br/>196&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  Title 58, Chapter 68, Utah Osteopathic Medical Practice Act.</u><br/>197&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  "Insurer" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=31a-1-301&session=2015GS">31A-1-301</a>.</u><br/>198&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4)  "Investigational device" means a device that:</u><br/>199&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  meets the definition of "investigational device" in 21 C.F.R. Sec. 812.3; and</u><br/>200&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  has successfully completed the United States Food and Drug Administration Phase</u><br/>201&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>1 testing for an investigational device described in 21 C.F.R. Part 812.</u><br/>202&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(5)  "Investigational drug" means a drug that:</u><br/>203&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  meets the definition of "investigational new drug" in 21 C.F.R. Sec. 312.3; and</u><br/>204&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  has successfully completed the United States Food and Drug Administration Phase</u><br/>205&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>1 testing for an investigational new drug described in 21 C.F.R. Part 312.</u><br/>206&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(6)  "Terminal illness" means a condition of a patient that:</u><br/>207&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  is serious or life-threatening;</u><br/>208&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  as determined by a physician, is likely to pose a greater risk to the patient than the</u><br/>209&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>risk posed to the patient by treatment with an investigational drug or investigational device;</u><br/>210&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and</u><br/>211&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  presents the patient with no treatment option that is satisfactory or comparable to</u><br/>212&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>treatment with an investigational drug or device.</u><br/>213&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 7.  Section <b>58-85-103</b><a name="58-85-103"></a> is enacted to read:<br/><hr>214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-85-103.</u></b>  <b>Right to request investigational drug or device.</b><br/>215&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  An eligible patient may obtain an investigational drug through an agreement with</u><br/>216&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the investigational drug's manufacturer and the eligible patient's physician that provides:</u><br/>217&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  for the transfer of the investigational drug from the manufacturer to the physician;</u><br/>218&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and</u><br/>219&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  that the physician will administer the investigational drug to the patient.</u><br/>220&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  An eligible patient may obtain an investigational device through an agreement with</u><br/>221&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the investigational device's manufacturer and the eligible patient's physician that provides:</u><br/>222&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  for the transfer of the investigational device from the manufacturer to the physician;</u><br/>223&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and</u><br/>224&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  that the physician will use the investigational device to treat the patient.</u><br/>225&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 8.  Section <b>58-85-104</b><a name="58-85-104"></a> is enacted to read:<br/>226&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-85-104.</u></b>  <b>Insurance coverage -- No right of action.</b><br/>227&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>This chapter does not:</u><br/>228&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  require an insurer to cover the cost of:</u><br/>229&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  administering an investigational drug under this chapter; or</u><br/>230&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  treating a patient with an investigational device under this chapter;</u><br/>231&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  prohibit an insurer from covering the cost of:</u><br/>232&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  administering an investigational drug under this chapter; or</u><br/>233&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  treating a patient with an investigational device under this chapter;</u><br/>234&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  require a manufacturer of an investigational drug or investigational device to agree</u><br/>235&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>to make an investigational drug or investigational device available to an eligible patient or an</u><br/>236&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>eligible patient's physician;</u><br/>237&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4)  require a physician to agree to:</u><br/>238&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  administer an investigational drug to an eligible patient under this chapter; or</u><br/>239&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  treat an eligible patient with an investigational device under this chapter; or</u><br/>240&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(5)  create a private right of action for any harm done to an eligible patient:</u><br/>241&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  resulting from the eligible patient's use of an investigational drug or investigational</u><br/>242&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>device, against:</u><br/>243&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  a manufacturer of an investigational drug or investigational device under this</u><br/>244&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>chapter;</u><br/><hr>245&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  a physician who administers an investigational drug or treats an eligible patient</u><br/>246&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>with an investigational device under this chapter; or</u><br/>247&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  a hospital where a physician administers an investigational drug to an eligible</u><br/>248&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>patient or treats an eligible patient with an investigational device under this chapter;</u><br/>249&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  against a physician or hospital, for the physician's or hospital's refusal to:</u><br/>250&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  administer an investigational drug to an eligible patient under this chapter; or</u><br/>251&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  treat an eligible patient with an investigational device under this chapter; or</u><br/>252&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  against a manufacturer, for the manufacturer's refusal to provide an eligible patient</u><br/>253&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>with an investigational drug or an investigational device under this chapter.</u><br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of   1-5-15  5:25 PM</b><br/><br/><div align="right"><b>Office of Legislative Research and General Counsel</b></div>
</font>
</div>
</body>
</html>
